NCT00662506 2023-06-06
Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
National Cancer Institute (NCI)
Phase 1/2 Completed
National Cancer Institute (NCI)
Jules Bordet Institute
University Health Network, Toronto
University of Arizona
University Hospital, Montpellier
Boston Medical Center
Washington University School of Medicine
University of Michigan Rogel Cancer Center
Abramson Cancer Center at Penn Medicine